- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04100200
Berries, Inflammation, and Gut Microbiome
Polyphenols and Human Gut Microbiome Interactions: Role of in Ameliorating Inflammation
Study Overview
Status
Conditions
Detailed Description
The proposed study will be conducted in humans according to Good Clinical Practice (GCP) guidelines. All subjects will review and sign an Informed Consent Form approved by the Illinois Institute of Technology's Institutional Review Boards (IRB) prior to screening.
This is a single-center, randomized, single-blinded, 4-arm, placebo-controlled clinical trial. It features an acute single exposure 24-h protocol and a chronic 4-week daily intake protocol to evaluate the effects of anthocyanins and ellagitannins from strawberry and red raspberry intake compared to a control diet, FOS, or FOS and berries combined on gut inflammation, in adults with chronic low-grade inflammation.
A planned sample size of 88 will be enrolled in the study. This study will require one initial screening visit, a pre-study visit, and 5 study visits. This study will take 5 weeks per subject to complete.
The initial screening visit will provide subject with their site-specific, IRB-approved informed consent document prior to the start of any study-related procedures. Subject eligibility will be determined through a high sensitivity C-Reactive Protein (hs-CRP) marker value, anthropometric measurements, vital signs, fasting blood glucose test (finger prick), and completion of a survey related to general eating, health, mood and exercise habits.
Eligible subjects will follow a limited polyphenolic diet throughout the duration of their participation, although stricter guidelines will be imposed during the 3 days prior to a study visit that involved blood/urine/fecal collection. Shopping lists and meal plans will be provided to subjects, along with counseling by the investigator's study investigators, to help subjects adhere to the limited polyphenolic diet. The trial will initiate with a 3-day food diary to assess background (pre-study) dietary intake followed by counseling to follow a diet relatively low in (poly)phenolic rich-beverages/foods, which will be maintained for the duration of the experiment. After an initial 7-day wash-in period on the limited polyphenolic diet, subjects will be randomized to 1 of 4 treatment sequences in the form of a drink: a mixed berries diet (raspberries and strawberries), a FOS diet (non-polyphenol, carbohydrate-based fermentable fiber/pre-biotic), a combination diet (mixed berries + FOS), or a control diet (negative control). Subjects will receive the same treatment for the duration of the study. Treatment codes will be maintained by the principal investigator.
Each visit will last ~2 hours and subjects will be required to remain at the Clinical Nutrition Research Center for the duration of the visit. Fasting blood samples will be collected at the 0 and 24h time points via a butterfly needle placed by a certified phlebotomist.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Di Xiao, MAS
- Phone Number: 312-567-5317
- Email: dxiao6@iit.edu
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60616
- Clinical Nutrition Research Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria
- C-Reactive Protein (hs-CRP) > 1.0 and ≤ 10 ng/L
- BMI ≥ 25 kg/m2
- Aged 20-60 years
- Able to provide informed consent and comply with study procedures
- Willing to maintain stable body weight and follow his/her habitual diet and physical activity patterns throughout the trial.
- Judged by the Investigator to be in general good health on the basis of medical history and screening laboratory tests.
- People with no documented disease condition that would interfere with the study endpoints (ie., CVD, diabetes, hypertension, major organ diseases) or taking medication or dietary supplements that may interfere with study endpoints
Exclusion Criteria
- Current smoker or marijuana user
- No history or presence of atherosclerosis/cardiovascular disease, inflammatory disease, diabetes mellitus, or other systemic diseases, psychological or psychiatric disorders that may interfere with study outcomes.
- Taking any medications and/or supplements that would interfere with outcomes of the study (i.e., lipid-lowering medications, anti-inflammatory drugs, etc)
- Take part in prebiotics, probiotics or drugs active on gastrointestinal motility or a laxative of any class within 1 month
- Unstable use of any medication/supplement, this could include marijuana used as -needed for medical reasons
- Have a history of cancer, except for non-melanoma skin cancer in past 5 years
- Addicted to drugs and/or alcohol (>4 drinks/day)
- Have been exposed to any non-registered drug product within last 30 days.
- Working overnight (e.g. 3rd shift of overnight workers)
- Excessive exercisers or trained athletes
- Have allergies/intolerances to any of the study products.
- Extreme dietary habits (ie. vegetarian/vegan)
- Excessive coffee/tea drinker (>4 cups/day)
- Actively losing weight/ trying to lose weight (unstable body weight fluctuations of > 5 kg in 3 months)
- Donated blood within last 3 months
- Participated in a clinical trial within 1 month
- Female who is pregnant, planning to be pregnant, breastfeeding
- Any condition the Investigator believes would interfere with his or her ability to provide informed consent or comply with the study protocol, or which might confound
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Mixed Berries
Strawberry and red raspberry composite served as a frozen drink
|
Strawberry and red raspberry
|
Active Comparator: FOS
Non-polyphenol, carbohydrate-based fermentable fiber/pre-biotic served as a frozen drink
|
Fructo-oligosaccharide
|
Active Comparator: Combination
Mixed berry composite + FOS served as a frozen drink
|
Mixed berry composite + FOS
|
Placebo Comparator: Control
Placebo similar in color to mixed berry supplement without any polyphenols served as a frozen drink
|
Placebo similar in color to mixed berry supplement without any polyphenols
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in plasma biomarkers and measures of inflammation concentration: Nrf2/ NF-κB -response between 4 treatments
Time Frame: Baseline to 4 weeks
|
Plasma biomarkers and measures of inflammation: Nrf2/ NF-κB activation in monocytes will be analyzed.
|
Baseline to 4 weeks
|
Changes in plasma biomarkers and measures of inflammation concentration-response between 4 treatments
Time Frame: Baseline to 4 weeks
|
Inflammatory cytokines (Interleukin-6 (IL-6), High Sensitivity C-Reactive Protein (hs-CRP), Tumor Necrosis Factor-α (TNF-α)) will be measured.
|
Baseline to 4 weeks
|
Changes in plasma biomarkers and measures of inflammation concentration (GLP-2)-response between 4 treatments
Time Frame: Baseline to 4 weeks
|
Analysis of GLP-2 will be done in plasma samples before and after chronic exposure to the study foods.
|
Baseline to 4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in gut inflammatory markers between 4 treatments.
Time Frame: Baseline to 4 weeks
|
The concentration of calprotectin, zonulin, and IgA in fecal samples will be determined by enzyme-linked immunosorbent assay (ELISA) before and after chronic exposure to study foods.
|
Baseline to 4 weeks
|
Changes in Bile acids between 4 treatments.
Time Frame: Baseline to 4 weeks
|
Bile acids in plasma and fecal samples will be determined using UHPLC-QQQ-MS.
|
Baseline to 4 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Characterize metabolite profiles (phenolic acids and urolithin derivatives) in urine and plasma.
Time Frame: Baseline to 4 weeks
|
Polyphenolic metabolites (anthocyanin, ellagitannins and other phenolic components) will be identified and quantified in urine and plasma.Metabolites in samples will be identified and quantified using an Agilent 6550 iFunnel UHPLC-QTOF-MS and 6460 UHPLC-QQQ-MS, respectively.
|
Baseline to 4 weeks
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Amandeep Sandhu, Ph.D, Institue for Food Safety and Health/Illinois Insititute of Technology
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB2018-121
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
University of PennsylvaniaActive, not recruitingHealthy | Healthy AgingUnited States
-
Chalmers University of TechnologyGöteborg UniversityCompletedHealthy | Nutrition, HealthySweden
-
Hasselt UniversityRecruitingHealthy | Healthy AgingBelgium
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
University of ManitobaNot yet recruitingHealthy | Healthy Diet
-
King's College LondonUniversity of ReadingCompletedHealthy | Healthy AgingUnited Kingdom
Clinical Trials on Mixed berries
-
Marjukka KolehmainenCompletedHyperglycemia | Blood Glucose, Postprandial | Blood Insulin, PostprandialFinland
-
University of HelsinkiCompletedCardiovascular DiseasesFinland
-
University of ManitobaRecruitingArterial StiffnessCanada
-
TCI Co., Ltd.CompletedSkin Condition | Anti Oxidative StressTaiwan
-
Kristianstad UniversityCompleted
-
National Research Council, SpainHospital Universitario 12 de OctubreCompleted
-
Probi ABLund UniversityCompletedLow-grade Inflammation | Increased Intestinal PermeabilitySweden
-
Marjukka KolehmainenWageningen University; VTT Technical Research Centre, FinlandCompletedObesity | Metabolic Syndrome | Impaired Glucose Tolerance | Impaired Fasting GlucoseFinland
-
University of LouisvilleJames Graham Brown Cancer CenterTerminated
-
Lund UniversityAnti-Diabetic Food CentreCompletedInflammation | Metabolic Syndrome | Aging | FermentationSweden